Refine Your Results

Click below to filter your search results

"Endometriosis"Undo
"Menopause"Undo

Search Results

Return to List
Results 1–1 of 1
Sort By: Relevance| Date| Title

Committee Opinion Number 738, June 2018

(Replaces Committee Opinion Number 663, June 2016)

ABSTRACT: Aromatase inhibitors have been used for the treatment of breast cancer, ovulation induction, endometriosis, and other estrogen-modulated conditions. For women with breast cancer, bone mineral density screening is recommended with long-term aromatase inhibitor use because of the risk of osteoporosis due to estrogen deficiency. Based on long-term adverse effects and complication safety data, when compared with tamoxifen, aromatase inhibitors are associated with a reduced incidence of thrombosis, endometrial cancer, and vaginal bleeding. For women with polycystic ovary syndrome, and a...


American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188